Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,707 | 88,244 | 45,325 | 51,352 | 74,157 |
| Receivables | 50,140 | 30,113 | 49,621 | 27,421 | 31,319 |
| Inventories | 171,801 | 179,810 | 177,732 | 172,906 | 163,116 |
| TOTAL | $318,193 | $303,691 | $276,419 | $257,013 | $273,699 |
| Non-Current Assets | |||||
| PPE Net | 53,694 | 54,326 | 55,317 | 53,835 | 54,815 |
| Intangibles | 4,015 | 4,009 | 3,851 | 4,029 | 4,006 |
| Other Non-Current Assets | 14,716 | 14,373 | 15,288 | 14,305 | 16,477 |
| TOTAL | $72,425 | $72,708 | $74,456 | $72,169 | $75,298 |
| Total Assets | $390,618 | $376,399 | $350,875 | $329,182 | $348,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,020 | 14,179 | 17,186 | 15,660 | 10,852 |
| Accrued Expenses | 27,535 | 27,726 | 33,691 | 32,919 | 29,864 |
| TOTAL | $44,891 | $44,177 | $53,088 | $49,806 | $41,841 |
| Non-Current Liabilities | |||||
| Long Term Debt | 101,326 | 131,074 | 130,847 | 130,594 | 142,026 |
| Deferred Revenues | 143 | 1,130 | 1,118 | 182 | 143 |
| Other Non-Current Liabilities | 2,063 | 2,078 | 2,093 | 2,107 | 2,002 |
| TOTAL | $113,837 | $143,953 | $144,081 | $144,170 | $155,718 |
| Total Liabilities | $158,728 | $188,130 | $197,169 | $193,976 | $197,559 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 236,390 | 233,083 | 231,809 | 228,220 | 225,968 |
| Common Shares | 24 | 23 | 23 | 23 | 23 |
| Retained earnings | -420,479 | -456,388 | -488,450 | -506,256 | -488,611 |
| TOTAL | $231,890 | $188,269 | $153,706 | $135,206 | $151,437 |
| Total Liabilities And Equity | $390,618 | $376,399 | $350,875 | $329,182 | $348,997 |